Genome Engineering for Humanity
PIPELINE
HM-201
Monoclonal antibody
HM-201
Neuroimmune disorder
- Neuroscience
- Discovery stage
- T-cell immune modulator
-
Indications
Neuroimmune disorder
-
Mechanism of Action
HM-201 is a fully human monoclonal antibody that is developed from our SynThese™ platform. Neuroimmune-modulatory function of HM-201 promotes the frequency of regulatory T cells (Treg) by restoring the imbalance in IL-1/ TGF levels.
-
Development status
This early discovery asset is currently set for preclinical studies. HuMab is accommodating medical institutes and industry partners from various research area (psychiatric disorders and neuroimmunology) to launch a research consortia.